Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 220
Selected: 0
NCT IDTitle
NCT03016494Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects
NCT04185805Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)
NCT06119945Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers
NCT04819932Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
NCT03364985Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers
NCT05226533Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
NCT01651858Nurigra Chewable Tablet in Healthy Adult Male Volunteers
NCT02069717Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)
NCT04888728To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
NCT02369302Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers
NCT04341428Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT03573622A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
NCT03024086Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
NCT01522586Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
NCT04592835To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
NCT06437951to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
NCT03184402Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
NCT05832697An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
NCT06212960Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT06109259Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
NCT05184179Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
NCT03439020The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent
NCT05816681Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
NCT05505994The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
NCT01964365Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers
NCT04541485To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
NCT03029533Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer
NCT07267221Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
NCT05410535To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
NCT06736587A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers
NCT06031987Long-term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes
NCT01629199Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
NCT05466643A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
NCT02622685A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects
NCT06399835Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
NCT02757144Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
NCT05192395A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
NCT05376969Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
NCT03574415Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
NCT02693522Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
NCT01634321The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
NCT07096921The Effect of Two Prokinetics in Patients With Functional Dyspepsia
NCT04524052To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
NCT07144176PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT06948487Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
NCT02332044Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers
NCT04003441Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
NCT04064073Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)
NCT01713920Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
NCT05747664To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function